We hypothesized that the chronic administration of the novel GR receptor modulator CORT113176 during chronic sleep restriction (SR) and opioid abstinence would reveal important effects on the HPA axis
Ins-1E cells were incubated for 1 h at 37 ºC with unlabelled apoA-I (0.9 mg/mL) and Alexa Fluor 488-labelled apoA-I (0.1 mg/mL) under basal glucose conditions. The cells were harvested and incubated
